http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102011122250-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_91015b0d0cc48e7e7eb768f9616cd3bb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-714 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-295 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-714 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26 |
| filingDate | 2011-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3cecb115b65ea3e48e14b056b410943 |
| publicationDate | 2013-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-102011122250-A1 |
| titleOfInvention | Ferrous vitamin composition |
| abstract | The present invention is a multiphase system for peroral application, preferably in the form of a multilayer tablet, which is suitable for the therapeutic and / or prophylactic treatment of mineral and / or vitamin deficiency, wherein the multiphase system has at least two different phases, in particular the multi-layer tablet at least two comprising different layers, wherein the multiphase system has at least one first phase, in particular the multi-layer tablet comprises at least a first layer, wherein the first phase, in particular the first layer, an active component (A) containing at least one physiologically acceptable and / or absorbable iron (II ) Compound, and having at least one second phase, in particular the multi-layer tablet comprises at least one second layer, wherein the second phase, in particular the second layer, an active ingredient component (B), which at least one vitamin, in especially at least one vitamin of the vitamin B group or its precursor, preferably vitamin B 9 (folic acid) including physiologically acceptable salts and esters of folic acid, in particular folates, and / or vitamin B 12 (cobalamin), wherein after peroral application the release of the active ingredient component (A) and the active ingredient component (B) is controllable, in particular with a time lag to each other, in particular the active ingredient component (A) releasable to the active ingredient component (B) is releasable. |
| priorityDate | 2011-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 278.